English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Study finds brain stimulation boosts focus but heightens threat response in depressed patients

+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Study links emotional openness with improved recovery outcomes for stroke survivors

+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Study finds no higher short-term stroke risk after cervical artery dissection with aneurysm

+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Antiplatelet use linked to higher mortality after brain bleeds in large US hospital study

+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Immunotherapy before surgery shows promise for treating rare skin cancer

+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Study finds young adults with childhood illnesses face longer stays in Canadian hospitals

+ Pharmaceuticals
Patient Daily | Feb 4, 2026

New clinical guide addresses UTI diagnosis amid rise in telehealth

+ Pharmaceuticals
Patient Daily | Feb 4, 2026

MD&M West 2026 exhibitors announce new products ahead of Anaheim convention

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily